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Abstract
Objective: The recommended treatment for cutaneous squamous cell cancer (CuSCC) of the head and neck is Mohs
surgical excision or wide local excision. Excision is recommended to a gross surgical margin of 4–6mm however this is
based on limited evidence and specify a goal histologic margin. The objective of this study was therefore to examine
the reported histological margin distance following WLE of advanced CuSCC and its association with recurrence and
survival.
Study design: Retrospective database review.
Setting: All patients included received treatment at UC Davis Department of Otolaryngology-Head and Neck Surgery
and/or Radiation Oncology in Sacramento, California.
Subjects and methods: The patients included were treated for advanced CuSCC with primary surgery with or without
adjuvant therapy. Kaplan Meier survival curves with log rank analysis were then performed to compare 5-year recurrence
free survival, and disease-specific survival for patients with different margin distances.
Results: Total number of subjects was 92. The overall 5-year DSS and RFS was 68.8 and 51.0% respectively. When the
pathological margin distance was ≥5mm, 5-year disease specific survival was improved when compared to margin
distance less than 5mm (94.7 vs 60.7 p = 0.034).
Conclusion: The findings of this study suggest that a histologic margin of at least 5mm may increase survival in advanced
head and neck CuSCC patients.
Introduction
Cutaneous squamous cell cancer (CuSCC) is the second
most common cancer, behind basal cell carcinoma with
an incidence of roughly 2 million cases per year in the
United States [1]. The majority of these cancers are
small and have an excellent cure and survival rate of
90–99% [1]. However, CuSCC if neglected or aggressive
does have the propensity to grow and destroy local
structures along with the ability to send local and distant
metastasis. CuSCC also has the tendency for more aggres-
sive behavior in patients who are immunocompromised
[2]. Management of CuSCC depends on several factors
including the size, location, metastatic disease, and patient
factors. In general, excision of the CuSCC with a normal
tissue margin is the standard treatment [3].
The gold standard of care for CuSCC and other skin
cancers is Moh’s surgical excision, which has a reported
cure rate of 96–99% [3, 4]. However, Moh’s surgical resec-
tion is not always possible. A second, highly effective
method of resection is wide local excision (WLE). This
too has a high cure rate of 90–97% and can often be used
when Mohs surgery is not indicated or available [3].
The treatment of CuSCC is outlined in the NCCN
guidelines. For “low-risk” CuSCCs of the head and neck
the recommended gross margins on surgical resections
are 4–6 mm [5]. Obtaining this margin in the head and
neck can be challenging given the proximity of vital
anatomy. For patients with high-risk features the guide-
lines recommend taking a larger margin, however the
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exact increase is not defined. The margin of 4–6 mm is
based on a single prospective non-randomized study that
used Moh’s technique. It recommended 4mm for tu-
mors less than 2 cm in greatest dimension and 6mm for
those greater than 2 cm. It did not examine whether a
4–6 mm margin via WLE was equivalent to a 4-6 mm
margin in Mohs nor did it study specific body site loca-
tion [4]. This study also describes only gross margins
and not histologic margins.
Histologic margin goals for CuSCC are not discussed
within the NCCN for CuSCC and there are no previous
papers that have addressed this topic. For oral mucosal
SCC the importance of histological margin distance is
well established. Loree et al orginally determined that a
histological margin of 5 mm or more results in greater
survival and less local recurrence than close or positive
margins [6, 7]. It is also recommended that taking a
gross 1 cm margin of mucosa will typically yield the
recommended 5mm histologic margin [8]. The precise
relationship between gross margin and histologic margin
is not known for CuSCC.
The objective of this study was to examine the re-
ported histologic margin distance following WLE of
advanced CuSCC and its association with recurrence
and survival.
Methods
This study was designed as a retrospective chart review.
Ethics approval was obtained from the University of Cali-
fornia ethics board. An established CuSCC database devel-
oped at UC Davis Otolaryngology-Head & Neck Surgery
was used to identify patients [9]. The database contained
patients treated from 1998 to 2014 for CuSCC of the head
and neck. All patients undergoing surgical treatment with
or without adjuvant therapy for curative intent were in-
cluded in the study. The database contained patient infor-
mation (age, sex, and immunologic status) and data
regarding tumor characteristics (primary site, DOI, diam-
eter, lymphovascular invasion, PNI, presence of regional
nodal disease, histologic differentiation, adjuvant therapy,
margin status, and whether tumors were recurrent on
presentation). Patients were considered immunocom-
promised if they were HIV+, on immunosuppression
drugs for transplantation, or undergoing chemotherapy.
The numbers of each type of immunosuppressed patient
were not recorded. All patients were treated in a head and
neck oncology practice and consequently all had advanced
stage (III & IV) disease as defined by primary tumor size ≥
4 cm, deep invasion (beyond subQ fat or > 6mm), bone
erosion, PNI, or presence of nodal disease.
For the surgical technique, a wide margin was marked
around the tumor site. The extent of the tumor was
based on palpation and visual inspection by the surgeon.
The gross margin taken by the surgeon was not recorded
in the database, therefore only the histologic margin
recorded by the pathologist was used in this study. Intra-
operative frozen sections were taken to confirm clear mar-
gins, as per NCCN guidelines. The frozen sections were
taken “off the patient” rather than off the specimen. The
exact method for analyzing the margins by the pathologist
is unknown, due to the retrospective nature of this study.
Statistical analyses were performed with SPSS 23.0
(SPSS Inc., Chicago, Illinois). A chi square analysis was
conducted to assess for a correlation between outcome
and margin status. The following factors were examined:
recurrent cancer, LVI, PNI, immunosuppression, poorly
differentiated SCC. Kaplan Meier survival curves with
log rank analysis were performed to assess 5-year recur-
rence free survival (RFS) and disease free survival (DSS)
at different margin distances.
Table 1 Patient Demographics and Tumor Characteristics
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Results
A total of 232 patients were entered in the database. 92
(40%) of these had a recorded histologic margin distance.
The remaining patients either had clear margins without
distance recorded (45%) or no primary cancer remaining
(15%). Demographic and tumor characteristics are sum-
marized in Table 1. Of the patients included in the study
the average age was 69 and the majority of participants
were male (85%) (Table 1). The overall 5-year disease spe-
cific survival and recurrence free survival was 68.8 and
51.0% respectively (Fig. 1).
For patients with recorded margins the average margin
distance was 3.6 mm. There was 55 patients with 0–2
mm margins (59%), 16 with 2-4 mm (17%), 6 with 4-6
mm (7%), 4 with 6-8 mm (4%), 6 with 8–10 mm margin
(7%), and 4 with > 10 mm margins (4%). Patients were
then divided into groups based on the distance of their
closest margin (< 1 vs ≥ 1 mm, < 2 vs ≥ 2 mm, … .. < 5
vs ≥ 5 mm). Kaplan Meier survival analysis was then used
to compare 5 year RFS and 5 year DSS between these
groups for each margin threshold (Fig. 2). At a margin
distance of ≥5 mm we observed significantly improved
DSS (94.7 vs 60.7 p = 0.034) and a non-significant trend
towards improved RFS (62.4 vs 47.9% p = 0.20).
A Chi-square analysis did not show any significant
correlation between margin distance and recurrent cancer,
LVI, PNI, immunosuppression, and poorly differentiated
CuSCC.
Discussion
There is a paucity of evidence regarding margin goals
for resection of CuSCC. The findings of this study
demonstrate that histologic margins of 5 mm or more
may increase survival in patients undergoing WLE for
advanced CuSCC of the head and neck. Examining
histologic margins in CuSCC in relation to survival has
not been examined before, however the results reflect
the recommendations for oral mucosa SCC [6, 7].
As previously mentioned the NCCN guidelines recom-
mend a gross margin of 4–6mm for CuSCC [5]. This was
based on a single study by Brodland and Zitelli from 1992
Fig. 1 The 5-year disease specific survival (68.8%) and recurrence free survival (51.0%) for all patients (N = 92)
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that used Mohs technique [4]. With Mohs technique the
surgeon performs both gross and histologic assessment of
the tumor at the time of resection. With WLE, surgeons
rely on visual and tactile feedback in taking appropriate
margins with selected use of frozen section. There have
been no studies examining whether a 4–6mm margin via
WLE is equivalent to a 4–6mm margin using Mohs. The
relationship of the gross margin compared to the final
histologic margin after WLE for CuSCC has not been
studied either. One study did specifically examine margin
shrinkage after Moh’s surgical excision and found a de-
crease in distance by 10% for head and neck specimens
[10]. Also, it is known that there is roughly a 10–17%
shrinkage of skin specimens after resection. Whether this
rate of shrinkage can be applied to margin distance after
WLE has not been assessed.
This study used closest histologic margins, meaning
that the distance reported by the pathologist after the
Fig. 2 Change in DSS and RFS as margin distance increases
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specimen underwent pathological processing. Histologic
margin goals are not addressed by the NCCN for
CuSCC and this is not a topic that has been previous
studied. For mucosal disease an established histologic
margin of 5mm is the recommendation to ensure in-
creased disease survival and decreased locoregional recur-
rence [7]. The shrinkage rate of oral mucosal specimens
have also been established, and having a 1 cm margin
intraorally should allow for a 5mm histologic margin [8].
Further prospective studies need to be performed to
establish this relationship for CuSCC.
A strength of this study is that it assessed CuSCC only
of the head and neck. Establishing treatment recommen-
dations specific to the head and neck is important as a
high proportion of skin cancers develop on the head and
neck, and the anatomy and lymphatic drainage of the
head and neck is unique. Also, given the functional and
aesthetic importance of the head and neck, appropriate
margin distance is paramount to minimizing the mor-
bidity of resection.
This study also distinguishes itself as it examined ad-
vanced head and neck CuSCC. All the patients in the
present study were considered advanced either due to size,
location, recurrence, or locoregional metastatic spread.
This study suggests that even with advanced disease, a > 5
mm histologic margin results in greater survival than a <
5mm margin.
Another limitation within the study is that only 40% of
patients within the database had reported margins. This
is possibly due to reporting standards changing for path-
ology. Therefore, it is possible that the 40% included in
the study could not be a representative sample.
One final point that was difficult to explain was why
DSS was associated with margin distance but RFS was
not. One would assume that patients who recur are
more likely to die of their disease and as such they
should be tightly associated. The correlation between
the margin status and DSS may be stronger than with
RFS because there was other prognostic factors that had
a significant influence on RFS, which “dilutes” this
correlation.
There are multiple directions that future studies could
take. A comparison of gross surgical margins, final histo-
logic margins and oncologic outcomes would certainly
be informative. This would help to determine what gross
margins are required to obtain a pathologic margin goal
of 5 mm or more. There is hope that data from outside
centers will eventually be added to the study to provide
more robust data.
Further work could also include examining high risk
patients. These include immunocompromised patients
such as transplant patients. This group of patients have
a much higher risk of developing CuSCC, have more
aggressive cancers, and worse outcomes. The NCCN
guidelines suggest taking a “larger margin” for these
patients, but do not specify how much larger [5]. The
European guidelines suggests 10 mm, but this is based
mainly on expert opinion [11]. It would be beneficial to
try to determine an appropriate margin distance in this
at-risk group of patients in order to guide management.
In conclusion, this study suggests that a 5 mm or
greater histologic margin may increase survival in head
and neck CuSCC patients, which correlates with the
recommendations for Oral SCC. Further prospective
studies are required to provide appropriate guidelines
for managing advanced or high risk CuSCC.
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